Skip to main content
Premium Trial:

Request an Annual Quote

NEWSBRIEF: Syrrx to Crack Protein Structures for Roche

NEW YORK, May 2 - Structural proteomics company Syrrx will provide high-throughput protein crystallization and protein-structure analysis for Roche, the company said today.

 

Syrrx will get an up-front technology access fee from the pharmaceutical company. The company may also be entitled to milestone payments, success payment, and license fees.

 

The firms did not reveal which proteins or therapeutic indications the arrangement covers.

 

Click here for more information.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.